Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:01:11 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



V:TTI - Thiogenesis Therapeutics, Corp. - http://www.thiogenesis.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TTI - V9.50.70·0.756.00.72    1.06  0.60May 01Apr 2915 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-29 09:24C:TTI0.75SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-29 09:24C:TTI0.75SEDAR MD & ASEDAR MD & A
2024-03-25 12:28C:TTI0.75News ReleaseThiogenesis CTA accepted by EMA for MELAS trial
2023-12-29 12:54C:TTI0.75Private PlacementThiogenesis 6,001,167-share private placement
2023-12-20 12:13C:TTI0.73News ReleaseThiogenesis closes $312,750 final tranche of financing
2023-12-18 12:53C:TTI0.74News ReleaseThiogenesis closes $4.18-million private placement
2023-11-27 13:35C:TTI0.80News ReleaseThiogenesis appoints Stanton as scientific adviser
2023-11-20 13:44C:TTI0.82News ReleaseThiogenesis arranges $4.5-million private placement
2023-11-17 12:43C:TTI0.82SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-17 12:41C:TTI0.82SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-24 09:15C:TTI0.65SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-24 09:15C:TTI0.65SEDAR Interim MD & ASEDAR Interim MD & A
2023-05-24 11:35C:TTI0.78SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-24 11:35C:TTI0.78SEDAR MD & ASEDAR MD & A
2023-05-10 14:05C:TTI0.77News ReleaseThiogenesis spends $1.1-million on R&D in 2022